SynthesisScientific reports2017

The efficacy and safety of SGLT2 inhibitors for adjunctive treatment of type 1 diabetes: a systematic review and meta-analysis.

Jiao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.